Janeen Doyle
Vermogen: 1 M $ op 31-07-2026
Vermogen: 1 M $ op 31-07-2026
Ms. Janeen Doyle is a Chief Corporate & Business Development Officer at Janux Therapeutics, Inc. Ms. Doyle was previously employed as a Senior VP-Strategy & Business Development by Bristol Myers Squibb Co. and a Senior VP-Strategy & Business Development by Celgene Corp.
She received her undergraduate degree from Moravian College and an MBA from the University of Scranton.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 02-06-2026 | 75.941 ( 0,13% ) | 1 M $ | 31-07-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| JANUX THERAPEUTICS, INC. | Corporate Officer/Principal | 15-05-2025 |
| Bedrijven | Functie | Einde |
|---|---|---|
| CELGENE | Corporate Officer/Principal | - |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Moravian College
Moravian College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Scranton
University of Scranton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Janux Therapeutics, Inc.
Janux Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company that develops precision engineered immunotherapies | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau